State-of-the-art imaging technologies are powerful tools that can be leveraged to study various cellular and molecular mechanisms in cancer progression and how tumor cells interact with the tumor microenvironment. The Cell Imaging Facility provides imaging modalities that cover the range from single molecule microscopy to whole animals, and from brightfield, to fluorescence and bioluminescence imaging. The Cell Imaging Facility offers bioluminescene/fluorescence in vivo imagers, microprobe lens-driven intravital microscope, multiphoton microscope, various fluorescence microscopes including macroview stereoscope, high content slide scanner and tissue cytometer, spinning disk confocal microscope, multispectral confocals with resonant scanner, integrated incubator microscope, structured illumination super-resolution microscope, laser microdissection system, and transmission electron microscope with 3D tomography capability. Collectively, this vast instrument portfolio offers core services in advanced microscopy on single molecules, macromolecular networks, live cells, FRET, FRAP, FLIP, photoconversion, TIRF, large tissue sections in bright field and fluorescence, specific tissue procurement, intravital imaging, and whole animal imaging. This creates a unique environment in which investigators can design workflow-based correlative experiments to study their cancer specimens all the way from whole animals to single molecules. This wide-ranging microscopy instrumentation and services is fully supported by the technical expertise of a team that has been consecutively recognized by the Northwestern University Office for Research as Outstanding Core for multiple years. The team is led by the facility director. Dr. Teng-Leong Chew. Dr. Chew is an expert in advanced live cell imaging, and has pioneered the development of several biosensors and imaging applications. Together the team provides active training and educational outreach in personalized instrument training, experimental consultation, seminars, journal clubs, hands-on workshops, as well as image analysis and programming boot camps. This 24-hr facility serves more than 180 labs throughout the university, and we maintain our leadership position in novel imaging technologies through a two-pronged approach: (i) aggressive and successful effort in securing shared instrument funds. We have added ten instruments over $300K since the last CCSG cycle;(ii) leveraging our expertise to attract leading manufacturers to establish beta test sites in the imaging center. These efforts have culminated in the facility being recognized by Nikon as one of only eight Nikon Imaging Centers in the world, allowing the cancer center to benefit immensely from the investment of Nikon's latest technologies. In 2012, we were selected by EuroBioimaging Consortium as the first American imaging center to join this trans-Atlantic multinational imaging network. These achievements place the Cancer Center uniquely at the forefront of cancer imaging technologies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA060553-19
Application #
8588462
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2018-07-31
Budget Start
2013-09-16
Budget End
2014-07-31
Support Year
19
Fiscal Year
2013
Total Cost
$136,533
Indirect Cost
$48,210
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Caralt, M; Uzarski, J S; Iacob, S et al. (2015) Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant 15:64-75
Gach, Johannes S; Achenbach, Chad J; Chromikova, Veronika et al. (2014) HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study. PLoS One 9:e85371
Hung, Andy H; Holbrook, Robert J; Rotz, Matthew W et al. (2014) Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation. ACS Nano 8:10168-77
Keller, Jacob Pearson; Homma, Kazuaki; Duan, Chongwen et al. (2014) Functional regulation of the SLC26-family protein prestin by calcium/calmodulin. J Neurosci 34:1325-32
Zhao, Baobing; Keerthivasan, Ganesan; Mei, Yang et al. (2014) Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis. Haematologica 99:1157-67
Jensen, Samuel A; Calvert, Andrea E; Volpert, Giora et al. (2014) Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc Natl Acad Sci U S A 111:5682-7
Daugherty, Rebecca L; Serebryannyy, Leonid; Yemelyanov, Alex et al. (2014) ?-Catenin is an inhibitor of transcription. Proc Natl Acad Sci U S A 111:5260-5
Anderson, Mark T; Dewenter, Lena; Maier, Berenike et al. (2014) Seminal plasma initiates a Neisseria gonorrhoeae transmission state. MBio 5:e01004-13
Cull, Elizabeth H; Altman, Jessica K (2014) Contemporary treatment of APL. Curr Hematol Malig Rep 9:193-201
Brahmer, J R; Lee, J W; Traynor, A M et al. (2014) Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503). Eur J Cancer 50:302-8

Showing the most recent 10 out of 316 publications